CaMK inhibitors

Calcium/calmodulin-dependent protein kinase (CaMK) inhibitors are a class of compounds that selectively block the activity of CaMK enzymes, which play crucial roles in various cellular processes. CaMKs are serine/threonine kinases activated by the binding of calcium ions (Ca2+) and calmodulin (CaM), a calcium-binding protein. Upon activation, CaMKs phosphorylate target proteins involved in signal transduction, gene expression, synaptic plasticity, and other cellular functions. Inhibiting CaMKs can modulate these processes and has potential therapeutic implications in conditions where aberrant CaMK activity is implicated, such as neurodegenerative diseases, cardiovascular disorders, and cancer. Various small molecule inhibitors have been developed to target different isoforms of CaMKs selectively, offering potential tools for both research and therapeutic development.